BioStock Investor Pitch: ExpreS2ion Biotechnologies
Danish ExpreS2ion Biotechnologies develops a portfolio of vaccines currently targeting Covid-19, breast cancer, influenza, malaria and, with the latest pipeline addition, the cytomegalovirus. The company is currently looking to raise 102 MSEK in a rights issue to finance the next step with the ES2B-C001 breast cancer vaccine. CEO Bent U. Frandsen tells us more about the ongoing activities in BioStock Investor Pitch today at 08.45 am.See the presentation at biostock.se : https://www.biostock.se/2023/04/biostock-investor-pitch-expres2ion-biotechnologies-2/